Antibiotic prophylaxis to prevent catheter-related infections in recombinant interleukin-2-treated patients.
Orcese
C
C
Borri
A
A
Besana
C
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D009369:Neoplasms / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D007376:Interleukin-2; D011994:Recombinant Proteins